 | • レポートコード：MRC2206A016 • 出版社/出版日：Persistence Market Research / 2022年3月30日 • レポート形態：英文、PDF、253ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートでは、世界の動物用医薬品調剤市場について広く調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の影響分析、市場規模分析・予測、製品別（中枢神経系薬剤、抗炎症剤、ホルモン＆代替品、抗炎症剤、その他）分析、動物種類別（伴侶動物、家畜）分析、形態別（経口剤、注射剤、その他）分析、地域別分析、競争分析、仮定、調査手法などの項目を掲載しております。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症の影響分析 ・市場規模分析・予測 ・世界の動物用医薬品調剤市場規模：製品別（中枢神経系薬剤、抗炎症剤、ホルモン＆代替品、抗炎症剤、その他） ・世界の動物用医薬品調剤市場規模：動物種類別（伴侶動物、家畜） ・世界の動物用医薬品調剤市場規模：形態別（経口剤、注射剤、その他） ・世界の動物用医薬品調剤市場規模：地域別 ・競争分析 ・仮定 ・調査手法 |
Animal Drug Compounding Market: Scope of the Report
The latest publication by Persistence Market Research on the global animal drug compounding market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for animal drug compounding products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the animal drug compounding market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the animal drug compounding market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the animal drug compounding market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the animal drug compounding market offers information divided into four important segments – product, animal type, formulation and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
CNS Agents
Anti-Infective Agents
Hormones and Substitutes
Anti-inflammatory Agents
Others
Animal Type
Companion Animals
Livestock Animals
Formulation
Injectable
Orally
Others
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa (MEA)
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for animal drug compounding over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the driving factors has expects to influence the growth of the animal drug compounding industry?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the animal drug compounding market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the animal drug compounding market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the animal drug compounding market are more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Method Innovation / Development Trends
4. Key Success Factors
4.1. Animal Healthcare Spending
4.2. Regulatory Scenario
4.3. 503A and 503B Pharmacy Comparative Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Increasing Number Of Compounded Animal Drugs Prescriptions For Economic Reasons
5.1.2. Animal Drug Compounding From Bulk Drug Substances
5.1.3. Critical Veterinary Drug Shortages
5.2. Forecast Factors – Relevance & Impact
5.2.1. Increasing Regulatory Inspections of Animal Drug Compounding Pharmacies
5.2.2. Rising FDA Approvals
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Trends
5.3.4. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID-19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By Product
6.4.2. Revenue By Country
6.5. 2020 Market Scenario
6.6. Quarter by Quarter Forecast
6.7. Projected recovery Quarter
6.8. Recovery Scenario – Short term, Midterm and Long Term Impact
7. Global Animal Drug Compounding Market Value (US$ Mn) Analysis 2016-2021 and Forecast, 2022-2031
7.1. Historical Market Value (US$ Mn) Analysis, 2016-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Animal Drug Compounding Market Analysis 2016-2021 and Forecast 2022-2031, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Product, 2016-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2031
8.3.1. CNS Agents
8.3.2. Anti-Infective Agents
8.3.3. Hormones and Substitutes
8.3.4. Anti-inflammatory Agents
8.3.5. Others
8.4. Market Attractiveness Analysis By Product
9. Global Animal Drug Compounding Market Analysis 2016-2021 and Forecast 2022-2031, By Animal Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) By Animal Type, 2016-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Animal Type, 2022-2031
9.3.1. Companion Animals
9.3.1.1. Dogs
9.3.1.2. Cats
9.3.1.3. Others
9.3.2. Livestock Animals
9.4. Market Attractiveness Analysis By Animal Type
10. Global Animal Drug Compounding Market Analysis 2016-2021 and Forecast 2022-2031, By Formulation
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) By Formulation, 2016-2021
10.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Formulation, 2022-2031
10.3.1. Oral
10.3.2. Injectable
10.3.3. Others
10.4. Market Attractiveness Analysis By Formulation
11. Global Animal Drug Compounding Market Analysis 2016-2021 and Forecast 2022-2031, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2021
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2031
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Animal Drug Compounding Market Analysis 2016-2021 and Forecast 2022-2031
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2021
12.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2022-2031
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Animal Type
12.3.4. By Formulation
12.4. Market Attractiveness Analysis
12.5. Drivers and Restraints – Impact Analysis
13. Latin America Animal Drug Compounding Market Analysis 2016-2021 and Forecast 2022-2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2021
13.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2022-2031
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Animal Type
13.3.4. By Formulation
13.4. Market Attractiveness Analysis
13.5. Drivers and Restraints – Impact Analysis
14. Europe Animal Drug Compounding Market Analysis 2016-2021 and Forecast 2022-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2021
14.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2022-2031
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By Animal Type
14.3.4. By Formulation
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints – Impact Analysis
15. East Asia Animal Drug Compounding Market Analysis 2016-2021 and Forecast 2022-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2021
15.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2022-2031
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product
15.3.3. By Animal Type
15.3.4. By Formulation
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints – Impact Analysis
16. South Asia Animal Drug Compounding Market Analysis 2016-2021 and Forecast 2022-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2021
16.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2022-2031
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Animal Type
16.3.4. By Formulation
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints – Impact Analysis
17. Oceania Animal Drug Compounding Market Analysis 2016-2021 and Forecast 2022-2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2021
17.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2022-2031
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Animal Type
17.3.4. By Formulation
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints – Impact Analysis
18. Middle East and Africa Animal Drug Compounding Market Analysis 2016-2021 and Forecast 2022-2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2021
18.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2022-2031
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By Animal Type
18.3.4. By Formulation
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints – Impact Analysis
19. Key Countries Animal Drug Compounding Market Analysis 2022 & 2031
19.1. U.S. Animal Drug Compounding Market Analysis
19.1.1. By Product
19.1.2. By Animal Type
19.1.3. By Formulation
19.2. Canada Animal Drug Compounding Market Analysis
19.2.1. By Product
19.2.2. By Animal Type
19.2.3. By Formulation
19.3. Brazil Animal Drug Compounding Market Analysis
19.3.1. By Product
19.3.2. By Animal Type
19.3.3. By Formulation
19.4. Mexico Animal Drug Compounding Market Analysis
19.4.1. By Product
19.4.2. By Animal Type
19.4.3. By Formulation
19.5. Argentina Animal Drug Compounding Market Analysis
19.5.1. By Product
19.5.2. By Animal Type
19.5.3. By Formulation
19.6. U.K. Animal Drug Compounding Market Analysis
19.6.1. By Product
19.6.2. By Animal Type
19.6.3. By Formulation
19.7. Germany Animal Drug Compounding Market Analysis
19.7.1. By Product
19.7.2. By Animal Type
19.7.3. By Formulation
19.8. France Animal Drug Compounding Market Analysis
19.8.1. By Product
19.8.2. By Animal Type
19.8.3. By Formulation
19.9. Italy Animal Drug Compounding Market Analysis
19.9.1. By Product
19.9.2. By Animal Type
19.9.3. By Formulation
19.10. Spain Animal Drug Compounding Market Analysis
19.10.1. By Product
19.10.2. By Animal Type
19.10.3. By Formulation
19.11. Russia Animal Drug Compounding Market Analysis
19.11.1. By Product
19.11.2. By Animal Type
19.11.3. By Formulation
19.12. Japan Animal Drug Compounding Market Analysis
19.12.1. By Product
19.12.2. By Animal Type
19.12.3. By Formulation
19.13. China Animal Drug Compounding Market Analysis
19.13.1. By Product
19.13.2. By Animal Type
19.13.3. By Formulation
19.14. South Korea Animal Drug Compounding Market Analysis
19.14.1. By Product
19.14.2. By Animal Type
19.14.3. By Formulation
19.15. India Animal Drug Compounding Market Analysis
19.15.1. By Product
19.15.2. By Animal Type
19.15.3. By Formulation
19.16. ASEAN Animal Drug Compounding Market Analysis
19.16.1. By Product
19.16.2. By Animal Type
19.16.3. By Formulation
19.17. Australia Animal Drug Compounding Market Analysis
19.17.1. By Product
19.17.2. By Animal Type
19.17.3. By Formulation
19.18. New Zealand Animal Drug Compounding Market Analysis
19.18.1. By Product
19.18.2. By Animal Type
19.18.3. By Formulation
19.19. GCC Countries Animal Drug Compounding Market Analysis
19.19.1. By Product
19.19.2. By Animal Type
19.19.3. By Formulation
19.20. South Africa Animal Drug Compounding Market Analysis
19.20.1. By Product
19.20.2. By Animal Type
19.20.3. By Formulation
20. Competition Analysis
20.1. Competition Deep Dive
20.1.1. Hoye’s Pharmacy
20.1.1.1. Overview
20.1.1.2. Product Portfolio
20.1.1.3. Profitability by Market Segments (Product/End User/Region)
20.1.1.4. Sales Footprint
20.1.1.5. Strategy Overview
20.1.1.5.1. Marketing Strategy
20.1.1.5.2. Product Strategy
20.1.1.5.3. Channel Strategy
20.1.2. Vertisis Custom Pharmacy
20.1.2.1. Overview
20.1.2.2. Product Portfolio
20.1.2.3. Profitability by Market Segments (Product/End User/Region)
20.1.2.4. Sales Footprint
20.1.2.5. Strategy Overview
20.1.2.5.1. Marketing Strategy
20.1.2.5.2. Product Strategy
20.1.2.5.3. Channel Strategy
20.1.3. Smith Caldwell Drug Stor
20.1.3.1. Overview
20.1.3.2. Product Portfolio
20.1.3.3. Profitability by Market Segments (Product/End User/Region)
20.1.3.4. Sales Footprint
20.1.3.5. Strategy Overview
20.1.3.5.1. Marketing Strategy
20.1.3.5.2. Product Strategy
20.1.3.5.3. Channel Strategy
20.1.4. Sixth Avenue Medical Pharmacy
20.1.4.1. Overview
20.1.4.2. Product Portfolio
20.1.4.3. Profitability by Market Segments (Product/End User/Region)
20.1.4.4. Sales Footprint
20.1.4.5. Strategy Overview
20.1.4.5.1. Marketing Strategy
20.1.4.5.2. Product Strategy
20.1.4.5.3. Channel Strategy
20.1.5. Dougherty’s Pharmacy
20.1.5.1. Overview
20.1.5.2. Product Portfolio
20.1.5.3. Profitability by Market Segments (Product/End User/Region)
20.1.5.4. Sales Footprint
20.1.5.5. Strategy Overview
20.1.5.5.1. Marketing Strategy
20.1.5.5.2. Product Strategy
20.1.5.5.3. Channel Strategy
20.1.6. Triangle Compounding Pharmacy Inc.
20.1.6.1. Overview
20.1.6.2. Product Portfolio
20.1.6.3. Profitability by Market Segments (Product/End User/Region)
20.1.6.4. Sales Footprint
20.1.6.5. Strategy Overview
20.1.6.5.1. Marketing Strategy
20.1.6.5.2. Product Strategy
20.1.6.5.3. Channel Strategy
20.1.7. Medisca Inc.
20.1.7.1. Overview
20.1.7.2. Product Portfolio
20.1.7.3. Profitability by Market Segments (Product/End User/Region)
20.1.7.4. Sales Footprint
20.1.7.5. Strategy Overview
20.1.7.5.1. Marketing Strategy
20.1.7.5.2. Product Strategy
20.1.7.5.3. Channel Strategy
20.1.8. Wedgewood Pharmacy
20.1.8.1. Overview
20.1.8.2. Product Portfolio
20.1.8.3. Profitability by Market Segments (Product/End User/Region)
20.1.8.4. Sales Footprint
20.1.8.5. Strategy Overview
20.1.8.5.1. Marketing Strategy
20.1.8.5.2. Product Strategy
20.1.8.5.3. Channel Strategy
20.1.9. Millers Pharmacy
20.1.9.1. Overview
20.1.9.2. Product Portfolio
20.1.9.3. Profitability by Market Segments (Product/End User/Region)
20.1.9.4. Sales Footprint
20.1.9.5. Strategy Overview
20.1.9.5.1. Marketing Strategy
20.1.9.5.2. Product Strategy
20.1.9.5.3. Channel Strategy
20.1.10. Chiron Compounding Pharmacy
20.1.10.1. Overview
20.1.10.2. Product Portfolio
20.1.10.3. Profitability by Market Segments (Product/End User/Region)
20.1.10.4. Sales Footprint
20.1.10.5. Strategy Overview
20.1.10.5.1. Marketing Strategy
20.1.10.5.2. Product Strategy
20.1.10.5.3. Channel Strategy
20.1.11. MEDS Canadian Compounding Pharmacy
20.1.11.1. Overview
20.1.11.2. Product Portfolio
20.1.11.3. Profitability by Market Segments (Product/End User/Region)
20.1.11.4. Sales Footprint
20.1.11.5. Strategy Overview
20.1.11.5.1. Marketing Strategy
20.1.11.5.2. Product Strategy
20.1.11.5.3. Channel Strategy
20.1.12. Aurora Compounding
20.1.12.1. Overview
20.1.12.2. Product Portfolio
20.1.12.3. Profitability by Market Segments (Product/End User/Region)
20.1.12.4. Sales Footprint
20.1.12.5. Strategy Overview
20.1.12.5.1. Marketing Strategy
20.1.12.5.2. Product Strategy
20.1.12.5.3. Channel Strategy
20.1.13. Pace Pharmacy
20.1.13.1. Overview
20.1.13.2. Product Portfolio
20.1.13.3. Profitability by Market Segments (Product/End User/Region)
20.1.13.4. Sales Footprint
20.1.13.5. Strategy Overview
20.1.13.5.1. Marketing Strategy
20.1.13.5.2. Product Strategy
20.1.13.5.3. Channel Strategy
20.1.14. Victoria Compounding Pharmacy
20.1.14.1. Overview
20.1.14.2. Product Portfolio
20.1.14.3. Profitability by Market Segments (Product/End User/Region)
20.1.14.4. Sales Footprint
20.1.14.5. Strategy Overview
20.1.14.5.1. Marketing Strategy
20.1.14.5.2. Product Strategy
20.1.14.5.3. Channel Strategy
20.1.15. Pratt’s Compounding Pharmacy
20.1.15.1. Overview
20.1.15.2. Product Portfolio
20.1.15.3. Profitability by Market Segments (Product/End User/Region)
20.1.15.4. Sales Footprint
20.1.15.5. Strategy Overview
20.1.15.5.1. Marketing Strategy
20.1.15.5.2. Product Strategy
20.1.15.5.3. Channel Strategy
20.1.16. People’s Choice Pharmacy
20.1.16.1. Overview
20.1.16.2. Product Portfolio
20.1.16.3. Profitability by Market Segments (Product/End User/Region)
20.1.16.4. Sales Footprint
20.1.16.5. Strategy Overview
20.1.16.5.1. Marketing Strategy
20.1.16.5.2. Product Strategy
20.1.16.5.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Table 01: 503A and 503B Pharmacy Comparative AnalysisTable 02: Global Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Product
Table 03: Global Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Animal Type
Table 04: Global Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Formulation
Table 05: Global Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Region
Table 06: North America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Country
Table 07: North America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Product
Table 08: North America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Animal Type
Table 09: North America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Formulation
Table 10: Latin America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Country
Table 11: Latin America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Product
Table 12: Latin America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Animal Type
Table 13: Latin America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Formulation
Table 14: Europe Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Country
Table 15: Europe Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Product
Table 16: Europe Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Animal Type
Table 17: Europe Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Formulation
Table 18: East Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Country
Table 19: East Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Product
Table 20: East Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Animal Type
Table 21: East Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Formulation
Table 22: South Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Country
Table 23: South Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Product
Table 24: South Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Animal Type
Table 25: South Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Formulation
Table 26: Oceania Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Country
Table 27: Oceania Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Product
Table 28: Oceania Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Animal Type
Table 29: Oceania Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Formulation
Table 30: MEA Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Country
Table 31: MEA Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Product
Table 32: MEA Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Animal Type
Table 33: MEA Animal Drug Compounding Market Value (US$ Mn) Analysis for 2016-2021, Estimate for 2022 and Forecast for 2022-2031, By Formulation